These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22803931)

  • 1. Reversibility of prion misfolding: insights from constant-pH molecular dynamics simulations.
    Vila-Viçosa D; Campos SR; Baptista AM; Machuqueiro M
    J Phys Chem B; 2012 Aug; 116(30):8812-21. PubMed ID: 22803931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant-pH molecular dynamics simulations reveal a β-rich form of the human prion protein.
    Campos SR; Machuqueiro M; Baptista AM
    J Phys Chem B; 2010 Oct; 114(39):12692-700. PubMed ID: 20843095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics studies on the buffalo prion protein.
    Zhang J; Wang F; Chatterjee S
    J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH on the human prion protein: insights into the early steps of misfolding.
    van der Kamp MW; Daggett V
    Biophys J; 2010 Oct; 99(7):2289-98. PubMed ID: 20923664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion versus doppel protein misfolding: new insights from replica-exchange molecular dynamics simulations.
    Baillod P; Garrec J; Tavernelli I; Rothlisberger U
    Biochemistry; 2013 Nov; 52(47):8518-26. PubMed ID: 24143866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism for low pH triggered misfolding of the human prion protein.
    DeMarco ML; Daggett V
    Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of the nucleated polymerization model of prion replication.
    Rubenstein R; Gray PC; Cleland TJ; Piltch MS; Hlavacek WS; Roberts RM; Ambrosiano J; Kim JI
    Biophys Chem; 2007 Feb; 125(2-3):360-7. PubMed ID: 17084016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.
    van der Kamp MW; Daggett V
    Top Curr Chem; 2011; 305():169-97. PubMed ID: 21526434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of the molecular chaperone Hsc70 to the prion protein PrP is modulated by pH and copper.
    Wilkins S; Choglay AA; Chapple JP; van der Spuy J; Rhie A; Birkett CR; Cheetham ME
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1226-32. PubMed ID: 20434583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring prion protein stability by NMR.
    Julien O; Graether SP; Sykes BD
    J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
    Colacino S; Tiana G; Broglia RA; Colombo G
    Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein.
    Alonso DO; An C; Daggett V
    Philos Trans A Math Phys Eng Sci; 2002 Jun; 360(1795):1165-78. PubMed ID: 12804272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics studies on 3D structures of the hydrophobic region PrP(109-136).
    Zhang J; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):509-19. PubMed ID: 23563221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.
    Guo J; Ren H; Ning L; Liu H; Yao X
    J Struct Biol; 2012 Jun; 178(3):225-32. PubMed ID: 22491059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.